| Tumor mutation burden as a biomarker in resected non–small-cell lung cancer S Devarakonda, F Rotolo, MS Tsao, I Lanc, E Brambilla, A Masood, ... Journal of Clinical Oncology 36 (30), 2995-3006, 2018 | 249 | 2018 |
| IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label … M Bagot, P Porcu, A Marie-Cardine, M Battistella, BM William, M Vermeer, ... The Lancet Oncology 20 (8), 1160-1170, 2019 | 152 | 2019 |
| parfm: Parametric Frailty Models in R M Munda, F Rotolo, C Legrand Journal of Statistical Software 51 (11), 2012 | 152 | 2012 |
| Empirical extensions of the lasso penalty to reduce the false discovery rate in high-dimensional Cox regression models N Ternès, F Rotolo, S Michiels Statistics in Medicine, 2016 | 103 | 2016 |
| Circular statistics U Lund, C Agostinelli, H Arai, A Gagliardi, EG Portugues, D Giunchi, ... R package version 4, 93, 2017 | 98* | 2017 |
| Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial RJ Kreitman, C Dearden, PL Zinzani, J Delgado, T Robak, PD le Coutre, ... Journal of hematology & oncology 14, 1-11, 2021 | 75 | 2021 |
| Surrogate end points for overall survival in loco-regionally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis F Rotolo, JP Pignon, J Bourhis, S Marguet, J Leclercq, W Tong Ng, J Ma, ... JNCI: Journal of the National Cancer Institute 109 (4), djw239, 2017 | 56 | 2017 |
| Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis B Lueza, F Rotolo, J Bonastre, JP Pignon, S Michiels BMC medical research methodology 16, 1-14, 2016 | 51 | 2016 |
| Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice S Michiels, N Ternès, F Rotolo Annals of Oncology 27 (12), 2160-2167, 2016 | 50 | 2016 |
| Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort M Kandel, C Allayous, S Dalle, L Mortier, S Dalac, C Dutriaux, MT Leccia, ... European Journal of Cancer 105, 33-40, 2018 | 49 | 2018 |
| Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients A Stoclin, F Rotolo, Y Hicheri, M Mons, E Chachaty, B Gachot, JP Pignon, ... Supportive Care in Cancer 28, 193-200, 2020 | 42 | 2020 |
| Combination of monalizumab and cetuximab in recurrent or metastatic head and neck cancer patients previously treated with platinum-based chemotherapy and PD-(L) 1 inhibitors. RB Cohen, JR Bauman, S Salas, AD Colevas, C Even, D Cupissol, ... Journal of Clinical Oncology 38 (15_suppl), 6516-6516, 2020 | 41 | 2020 |
| surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials F Rotolo, X Paoletti, S Michiels Computer methods and programs in biomedicine 155, 189-198, 2018 | 41* | 2018 |
| Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces N Ternes, F Rotolo, G Heinze, S Michiels Biometrical Journal 59 (4), 685-701, 2017 | 40 | 2017 |
| A simulation procedure based on copulas to generate clustered multi-state survival data F Rotolo, C Legrand, I Van Keilegom Computer Methods and Programs in Biomedicine 109 (3), 305-312, 2013 | 34 | 2013 |
| Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach F Rotolo, A Dunant, T Le Chevalier, JP Pignon, R Arriagada Annals of Oncology 25 (11), 2162-2166, 2014 | 33* | 2014 |
| Avdoralimab (anti-C5aR1 mAb) versus placebo in patients with severe COVID-19: results from a randomized controlled trial (FOR COVID Elimination [FORCE]) J Carvelli, F Meziani, J Dellamonica, PY Cordier, J Allardet-Servent, ... Critical Care Medicine 50 (12), 1788-1798, 2022 | 25* | 2022 |
| Predictor of effectiveness of treatment intensification on overall survival in head and neck cancer (HNC) K Zakeri, F Rotolo, B Lacas, LK Vitzthum, QTX Le, V Gregoire, ... Annals of Oncology 29, viii375-viii376, 2018 | 23* | 2018 |
| French intensive care society, international congress-réanimation 2016 E Jaillette, C Girault, G Brunin, F Zerimech, A Chiche, ... Annals of Intensive Care 6 (Suppl 1), 50-50, 2016 | 23 | 2016 |
| Accounting for grouped predictor variables or pathways in high-dimensional penalized Cox regression models S Belhechmi, RD Bin, F Rotolo, S Michiels BMC bioinformatics 21, 1-20, 2020 | 20 | 2020 |
Stefan MichielsOffice Biostatistics & Epidemiology, Gustave Roussy; Oncostat, Univ. Paris Saclay, INSERMVerified email at gustaveroussy.fr